Coated platelets function in platelet-dependent fibrin formation via integrin αIIbβ3 and transglutaminase factor XIII

Haematologica

Volumn 101, Issue 4, 2016, Pages 427-436

  Mattheij, Nadine J A ^a   Swieringa, Frauke ^a   Mastenbroek, Tom G ^a   Berny Lang, Michelle A ^b   May, Frauke ^c   Baaten, Constance C F M J ^a   van der Meijden, Paola E J ^a   Henskens, Yvonne M C ^d   Beckers, Erik A M ^d   Suylen, Dennis P L ^a   Nolte, Marc W ^c   Hackeng, Tilman M ^a   McCarty, Owen J T ^b   Heemskerk, Johan W M ^a   Cosemans, Judith M E M ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b Oregon Health and Science University Department of Biomedical Engineering   (United States)

^c CSL BEHRING GMBH   (Germany)

^d MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTEGRIN; BLOOD CLOTTING FACTOR 13; CONVULXIN; FIBRINOGEN; INTEGRIN ALPHA 2B BETA 3; LIPOCORTIN 5; PHOSPHATIDYLSERINE; THROMBIN; UNCLASSIFIED DRUG; BLOOD CLOTTING FACTOR 10A; BLOOD CLOTTING FACTOR 5A; FIBRIN; FIBRINOGEN RECEPTOR; LECTIN; MOLECULAR PROBE; PROTEIN BINDING; SNAKE VENOM;

ARTICLE; BLOOD CLOTTING; COATED THROMBOCYTE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; FIBRIN FORMATION; FLOW CYTOMETRY; FLUORESCENCE; GLANZMANN DISEASE; HUMAN; THROMBOCYTE; THROMBOCYTE ACTIVATION; ANIMAL; BLOOD; CHEMISTRY; DRUG EFFECTS; KNOCKOUT MOUSE; METABOLISM; MOLECULAR PROBE; MOUSE; PATHOLOGY; PRIMARY CELL CULTURE;

ANIMALS; BLOOD COAGULATION; BLOOD PLATELETS; CROTALID VENOMS; FACTOR VA; FACTOR XA; FACTOR XIII; FIBRIN; FIBRINOGEN; HUMANS; LECTINS, C-TYPE; MICE; MICE, KNOCKOUT; MOLECULAR PROBES; PHOSPHATIDYLSERINES; PLATELET ACTIVATION; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX; PRIMARY CELL CULTURE; PROTEIN BINDING; THROMBASTHENIA; THROMBIN;

EID: 84962419509     PISSN: 03906078     EISSN: 15928721     Source Type: Journal    
DOI: 10.3324/haematol.2015.131441     Document Type: Article

References (38)

1. Cosemans JM, Angelillo-Scherrer A, Mattheij NJ, Heemskerk JW. The effects of arterial flow on platelet activation, thrombus growth, and stabilization. Cardiovasc Res. 2013; 99(2): 342-352.
2. de Witt SM, Swieringa F, Cavill R, et al. Identification of platelet function defects by multi-parameter assessment of thrombus formation. Nat Commun. 2014; 5: 4257.
3. Munnix IC, Cosemans JM, Auger JM, Heemskerk JW. Platelet response heterogeneity in thrombus formation. Thromb Haemost. 2009; 102(6): 1149-1156.
4. Versteeg HH, Heemskerk JW, Levi M, Reitsma PH. New fundamentals in hemostasis. Physiol Rev. 2013; 93(1): 327-358.
5. Heemskerk JW, Mattheij NJ, Cosemans JM. Platelet-based coagulation: different populations, different functions. J Thromb Haemost. 2013; 11(1): 2-16.
6. Mattheij NJ, Gilio K, van Kruchten R, et al. Dual mechanism of integrin αIIβ3 closure in procoagulant platelets. J Biol Chem. 2013; 288(19): 13325-13336.
7. Dale GL. Coated-platelets: an emerging component of the procoagulant response. J Thromb Haemost. 2005; 3(10): 2185-2192.
8. Dale GL, Friese P, Batar P, et al. Stimulated platelets use serotonin to enhance their retention of procoagulant proteins on the cell surface. Nature. 2002; 415(6868): 175-179.
9. Alberio LJ, Clemetson KJ. All platelets are not equal: COAT platelets. Curr Hematol Rep. 2004; 3(5): 338-343.
10. Szasz R, Dale GL. Thrombospondin and fibrinogen bind serotonin-derivatized proteins on COAT-platelets. Blood. 2002; 100(8): 2827-2831.
11. Maroney SA, Haberichter SL, Friese P, et al. Active tissue factor pathway inhibitor is expressed on the surface of coated platelets. Blood. 2007; 109(5): 1931-1937.
12. Jobe SM, Leo L, Eastvold JS, et al. Role of FcRFγ and factor XIIIA in coated platelet formation. Blood. 2005; 106(13): 4146-4151.
13. Kirkpatrick AC, Tafur AJ, Vincent AS, Dale GL, Prodan CI. Coated-platelets improve prediction of stroke and transient ischemic attack in asymptomatic internal carotid artery stenosis. Stroke. 2014; 45(10): 2995-3001.
14. Prodan CI, Stoner JA, Cowan LD, Dale GL. Higher coated-platelet levels are associated with stroke recurrence following nonlacunar brain infarction. J Cereb Blood Flow Metab. 2013; 33(2): 287-292.
15. Prodan CI, Vincent AS, Dale GL. Coatedplatelet levels are persistently elevated in patients with mild traumatic brain injury. J Head Trauma Rehabil. 2014; 29(6): 522-526.
16. Rosado JA, Meijer EM, Hamulyak K, Novakova I, Heemskerk JW, Sage SO. Fibrinogen binding to the integrin FIIbI3 modulates store-mediated calcium entry in human platelets. Blood. 2001; 97(9): 2648-2656.
17. Lauer P, Metzner HJ, Zettlmeissl G, et al. Targeted inactivation of the mouse locus encoding coagulation factor XIII-A: hemostatic abnormalities in mutant mice and characterization of the coagulation deficit. Thromb Haemost. 2002; 88(6): 967-974.
18. Gilio K, Harper MT, Cosemans JM, et al. Functional divergence of platelet protein kinase C (PKC) isoforms in thrombus formation on collagen. J Biol Chem. 2010; 285(30): 23410-23419.
19. Van der Meijden PE, Feijge MA, Swieringa F, et al. Key role of integrin αIIβ3 signaling to Syk kinase in tissue factor-induced thrombin generation. Cell Mol Life Sci. 2012; 69(20): 3481-3492.
20. Vanschoonbeek K, Wouters K, van der Meijden PE, et al. Anticoagulant effect of dietary fish oil in hyperlipidemia: a study of hepatic gene expression in APOE2 knock-in mice. Arterioscler Thromb Vasc Biol. 2008; 28(11): 2023-2029.
21. Hemker HC, Giesen P, Al Dieri R, et al. Calibrated automated thrombin generation measurement in clotting plasma. Pathophysiol Haemost Thromb. 2003; 33 (1): 4-15.
22. Gilio K, van Kruchten R, Braun A, et al. Roles of STIM1 and Orai1 in glycoprotein VI-and thrombin-dependent procoagulant activity and thrombus formation. J Biol Chem. 2010; 285: 23629-23638.
23. Van Kruchten R, Cosemans JMEM, Heemskerk JWM. Measurement of whole blood thrombus formation using parallelplate flow chambers: a practical guide. Platelets. 2012; 23(31): 229-242.
24. Cosemans JM, Munnix IC, Wetzker R, Heller R, Jackson SP, Heemskerk JW. Continuous signaling via PI3K isoforms β and γ is required for platelet ADP receptor function in dynamic thrombus stabilization. Blood. 2006; 108(9): 3045-3052.
25. Miserus RJ, Herías MV, Prinzen L, et al. Molecular MRI of early thrombus formation using a bimodal alpha2-antiplasminbased contrast agent. JACC Cardiovasc Imaging. 2009; 2(8): 987-996.
26. Abaeva AA, Canault M, Kotova YN, et al. Procoagulant platelets form an P-granule protein-covered "cap" on their surface that promotes their attachment to aggregates. J Biol Chem. 2013; 288(41): 29621-29632.
27. Cosemans JM, Schols SE, Stefanini L, et al. Key role of glycoprotein Ib/V/IX and von Willebrand factor in platelet activationdependent fibrin formation at low shear flow. Blood. 2011; 117(2): 651-660.
28. Zeiler M, Moser M, Mann M. Copy number analysis of the murine platelet proteome spanning the complete abundance range. Mol Cell Proteomics. 2014; 13(12): 3435-3445.
29. London FS, Marcinkiewicz M, Walsh PN. A subpopulation of platelets responds to thrombin-or SFLLRN-stimulation with binding sites for factor IXa. J Biol Chem. 2004; 279(19): 19854-19859.
30. Panteleev MA, Ananyeva NM, Greco NJ, Ataullakhanov FI, Saenko EL. Two subpopulations of thrombin-activated platelets differ in their binding of the components of the intrinsic factor X-activating complex. J Thromb Haemost. 2005; 3(11): 2545-2553.
31. Kulkarni S, Jackson SP. Platelet factor XIII and calpain negatively regulate integrin aIIbI3 adhesive function and thrombus growth. J Biol Chem. 2004; 279(29): 30697-30706.
32. Podolnikova NP, Yakovlev S, Yakubenko VP, Wang X, Gorkun OV, Ugarova TP. The interaction of integrin iIIbI3 with fibrin occurs through multiple binding sites in the αIIβ3-propeller domain. J Biol Chem. 2014; 289(4): 2371-2783.
33. Nikolajsen CL, Dyrlund TF, Poulsen ET, Enghild JJ, Scavenius C. Coagulation factor XIIIa substrates in human plasma: identification and incorporation into the clot. J Biol Chem. 2014; 289(10): 6526-6534.
34. Siebenlist KR, Meh DA, Mosesson MW. Protransglutaminase (factor XIII) mediated crosslinking of fibrinogen and fibrin. Thromb Haemost. 2001; 86(5): 1221-1228.
35. Nurden AT, Nurden P. Inherited disorders of platelet function: selected updates. J Thromb Haemost. 2015; 13 Suppl 1: S2-9.
36. Puszkin EG, Raghuraman V. Catalytic properties of a calmodulin-regulated transglutaminase from human platelet and chicken gizzard. J Biol Chem. 1985; 260(29): 16012-16020.
37. Burkhart JM, Vaudel M, Gambaryan S, et al. The first comprehensive and quantitative analysis of human platelet protein composition allows the comparative analysis of structural and functional pathways. Blood. 2012; 120(15): e73-82.
38. Mitchell JL, Lionikiene AS, Fraser SR, Whyte CS, Booth NA, Mutch NJ. Functional factor XIII-A is exposed on the stimulated platelet surface. Blood. 2014; 124 (26): 3983-3990.